The Role of Vitamin K on Knee Osteoarthritis Outcomes

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

June 3, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Osteo Arthritis Knee
Interventions
DRUG

Vitamin K1 500 µg

One pill daily for 4 weeks.

DRUG

K1 1000 µg

One pill daily for 4 weeks.

DRUG

Vitamin K2 (MK-7) 300 µg

One pill daily for 4 weeks.

OTHER

Placebo

Placebo pill daily for 4 weeks.

Trial Locations (1)

02118

RECRUITING

Boston Medical Center, Rheumatology Clinic, Boston

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

Boston University

OTHER

NCT06385275 - The Role of Vitamin K on Knee Osteoarthritis Outcomes | Biotech Hunter | Biotech Hunter